Published: Guidance, quality standards and advice
Showing 21 to 24 of 24
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis | TA814 | ||
| Pralsetinib for treating RET fusion-positive advanced non-small-cell lung cancer | TA812 | ||
| Bioresorbable stent implantation to treat coronary artery disease | HTG633 | ||
| Aortic remodelling hybrid stent insertion during surgical repair of an acute type A aortic dissection | HTG634 |